Kostik Mikhail, Akca Kaya Ummusen, Zhogova Olga V, Sag Erdal, Suspitsin Evgeny N, Nizhnik Viktoriya I, Tumakova Anastasiya V, Ivanovskiy Sergey V, Lagunova Natalia V, Bilginer Yelda, Ozen Seza
St. Petersburg State Pediatric Medical University, Hospital Pediatry, Saint-Petersburg, Russia.
Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Turk Arch Pediatr. 2022 Sep;57(5):551-557. doi: 10.5152/TurkArchPediatr.2022.22106.
We aimed to evaluate the clinical and laboratory features and MEFV allele distribution in Crimean Tatar familial Mediterranean fever patients and to compare them with Turkish familial Mediterranean fever patients and healthy controls.
All newly diagnosed familial Mediterranean fever patients with Crimean Tatar nationality (n = 18) in Children's Regional Hospital in Simferopol were enrolled in the study and were compared to 40 familial Mediterranean fever cases followed up at Hacettepe University, Ankara, Turkey. The distribution of MEFV alleles was assessed in the 127 unrelated healthy Crimean Tatar adults aged 20 years or more from different parts of the Crimea peninsula.
Age and gender distribution, the frequency of colchicine resistance, and colchicine intolerance were similar between Turkish and Crimean Tatar children with familial Mediterranean fever. The duration of familial Mediterranean fever attack was shorter in Turkish patients than in Crimean Tatar (2.0 vs. 3.0 days, P < .001). Chest pain was more frequent in Turkish familial Mediterranean fever patients, whereas arthralgia, arthritis, and erysipeloid rash were more common in Crimean TatarT. MEFV allele distribution in Crimean Tatar was M694V-81%, M680I and V726A 9.5% both, and 68.6%, 14.3%, and 12.9% in Turkish, consequently. Homozygous carriers were 11%, compound-heterozygous was 6%, and heterozygous was 83%, compared to Turkish being 45%, 30%, and 25%, respectively. The allele distribution in healthy Crimean Tatar and Turkish was 10.2% and M694V was 7.1%, M680I was 1.6%, and V726A was 1.6%.
The similar MEFV allele prevalence in both populations suggests the high prevalence of familial Mediterranean fever and the high number of undiagnosed patients in the Crimea peninsula. Younger age at onset, shorter duration of attacks, the prevalence of articular involvement, and erysipeloid rash were distinctive features of familial Mediterranean fever in Crimean Tatar.
我们旨在评估克里米亚鞑靼族家族性地中海热患者的临床和实验室特征以及MEFV等位基因分布,并将其与土耳其家族性地中海热患者及健康对照进行比较。
辛菲罗波尔儿童地区医院所有新诊断的克里米亚鞑靼族家族性地中海热患者(n = 18)纳入本研究,并与土耳其安卡拉哈杰泰佩大学随访的40例家族性地中海热病例进行比较。对来自克里米亚半岛不同地区的127名20岁及以上无亲缘关系的健康克里米亚鞑靼族成年人评估MEFV等位基因分布。
土耳其和克里米亚鞑靼族家族性地中海热儿童的年龄和性别分布、秋水仙碱耐药频率及秋水仙碱不耐受情况相似。土耳其患者家族性地中海热发作的持续时间比克里米亚鞑靼族患者短(2.0天对3.0天,P <.001)。胸痛在土耳其家族性地中海热患者中更常见,而关节痛、关节炎和丹毒样皮疹在克里米亚鞑靼族中更常见。克里米亚鞑靼族中MEFV等位基因分布为M694V - 81%,M680I和V726A均为9.5%,而在土耳其分别为68.6%、14.3%和12.9%。纯合子携带者在克里米亚鞑靼族中为11%,复合杂合子为6%,杂合子为83%,而在土耳其分别为45%、30%和